Supernus Pharmaceuticals Inc (NASDAQ:SUPN)
| 32.10 Delayed Data As of Jun 18 |  -0.48 / -1.47%Today’s Change | 17.20 Today|||52-Week Range 34.29 | +27.58% Year-to-Date |
Latest SUPN News | Press Releases
| Is First Trust Small Cap Value AlphaDEX ETF (FYT) a Strong ETF Right Now? Jun 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 32.58 |
| Today’s open | 31.82 |
| Day’s range | 31.28 - 32.36 |
| Volume | 28,802 |
| Average volume (3 months) | 538,837 |
| Market cap | $1.7B |
Data as of 4:00pm ET, 06/18/2021
Growth & Valuation
| Earnings growth (last year) | +11.85% |
| Earnings growth (this year) | -55.08% |
| Earnings growth (next 5 years) | -22.60% |
| Revenue growth (last year) | +32.50% |
| P/E ratio | 15.5 |
| Price/Sales | 2.60 |
| Price/Book | 2.20 |
Competitors
Data as of 3:59pm ET, 06/18/2021
Financials
| Next reporting date | August 4, 2021 |
| EPS forecast (this quarter) | $0.24 |
| Annual revenue (last year) | $520.4M |
| Annual profit (last year) | $127.0M |
| Net profit margin | 24.39% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Rockville, Maryland |
Forecasts
